Change over period: —
NSE · ROSSARI
ROSSARI
-31.8% from the 52-week high · +14.3% above the low
Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. The company is headquartered in Mumbai, Maharashtra and currently employs 500 full-time employees. The company went IPO on 2020-07-23. The firm is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. The company operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. The company provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.
The short version. ROSSARI reported revenue of ₹698 crore for Sep 2026, up 19.1% from a year earlier. Net profit was ₹39 crore (up 5.4% year on year). Return on equity was 11.2% in Mar 2026. Promoter holding was 68.14% in Sep 2026, down 0.05 points over 8 quarters.
1 · The price
How has the stock traded?
ROSSARI trades 31.8% below its 52-week high and 14.3% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹698 cr.
Sep 2026 net profit of ₹39 cr.
0.7 pts lower than a year earlier.
Revenue compounded at 13.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 698 | 697 | 685 | 582 | 586 | 544 | 580 | 513 |
| Net profit | 39 | 35 | 46 | 33 | 37 | 34 | 34 | 32 |
| Net margin % | 5.6 | 5.0 | 6.7 | 5.6 | 6.3 | 6.2 | 5.9 | 6.2 |
| EPS (₹) | 7.02 | 6.34 | 8.3 | 5.92 | 6.66 | 6.07 | 6.22 | 5.73 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2396 | 2080 | 1831 | 1656 | 1483 | 709 |
| Net profit | 149 | 136 | 131 | 107 | 98 | 80 |
| Net margin % | 6.2 | 6.6 | 7.1 | 6.5 | 6.6 | 11.3 |
| EPS (₹) | 26.94 | 24.63 | 23.66 | 19.45 | 17.74 | 15.45 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 11.2% in Mar 2026; debt to equity is 0.31.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 11.2 | 11.5 | 12.5 | 11.7 |
| Return on capital % | 15.3 | 14.9 | 17.2 | 16.2 |
| EBITDA margin % | 12.8 | 12.9 | 14.0 | 13.8 |
| Net margin % | 6.2 | 6.5 | 7.1 | 6.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 13.3% | 27.5% |
| Profit CAGR | 11.6% | 13.2% |
4 · The owners
Who holds it, and are they adding?
Down 0.05 pts over 8 quarters.
Down 1.9 pts over 8 quarters.
Down 3.28 pts over 8 quarters.
+1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.19 | 68.18 | 68.17 | 68.17 | 68.16 | 68.15 | 68.14 | 68.14 | -0.05 |
| FII | 3.74 | 3.98 | 3.48 | 2.69 | 2.33 | 2.18 | 2.02 | 1.84 | -1.9 |
| DII | 17.47 | 17.59 | 17.84 | 18.18 | 18.26 | 18.2 | 14.64 | 14.19 | -3.28 |
| Public | 10.6 | 10.25 | 10.51 | 10.95 | 11.26 | 11.46 | 15.2 | 15.83 | +5.23 |
Mutual fund holdings · Oct 2026
9 schemes hold this stock
8 the month before.
- UTI Small Cap Fund0.48% of NAV
- UTI Multi Cap Fund0.39% of NAV
- CANARA ROBECO SMALL CAP FUND0.31% of NAV
- UTI - Flexi Cap Fund0.3% of NAV
- UTI Large & Mid Cap Fund0.21% of NAV
- UTI Aggressive Hybrid Fund0.18% of NAV
- MOTILAL OSWAL SMALL CAP FUND0.17% of NAV
- UTI Retirement Fund0.11% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ROSSARI are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about ROSSARI
What is the ROSSARI share price?
ROSSARI (ROSSARI) last closed at ₹428.00, down 1.1% on the day. Its 52-week range is ₹378.60 to ₹634.65.
What is the market cap of ROSSARI?
ROSSARI has a market capitalisation of about ₹2,389 crore. Its price-to-earnings ratio is 15.7.
How are ROSSARI's latest results?
ROSSARI reported revenue of ₹698 crore for Sep 2026, up 19.1% from a year earlier. Net profit was ₹39 crore (up 5.4% year on year). Return on equity was 11.2% in Mar 2026. Promoter holding was 68.14% in Sep 2026, down 0.05 points over 8 quarters.
Who owns ROSSARI?
As of Sep 2026, shareholding was: Promoter 68.14%, FII 1.84%, DII 14.19%, Public 15.83%.
How many mutual funds hold ROSSARI?
9 mutual fund schemes held ROSSARI in October 2026. That compares with 8 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 10 Jul 2026 · Final Dividend - Rs. 0.5
- 20 Jun 2025 · Final Dividend - Rs. 0.5
- 16 Aug 2024 · Final Dividend - Rs. 0.5
- 24 May 2023 · Final Dividend - Rs. 0.5
- 07 Jul 2022 · Final Dividend - Rs. 0.5
- 08 Sep 2021 · Final Dividend - Rs. 0.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.